PROC
Procaps Group S.A.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · LU
$1.01
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 1.94x
- PEG TTM
- —
- Price / book
- 2.63x
- Price / sales
- 0.25x
- Price / cash flow
- 1.64x
Enterprise value
- Enterprise value
- $374.9M
- EV / sales
- 0.91x
- EV / EBITDA
- 3.12x
- EV / EBIT
- 4.00x
- Market cap
- $103.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2023